A North Carolina Integrated Research Organization (IRO) has partnered with a local medical practice to implement advanced regional clinical research as a care option, offering a more aligned, efficient, and effective solution to the challenges of patient inclusion in the ever-increasing complexity and cost of drug development.
TrialSite News wrote about Javara late last year. We summarized the participants of this partnership and their stated model. Most physicians and patients don’t participate in clinical research. Javara aims to change that by bringing turnkey clinical research services to physician networks and other practices.
Tryon Medical Partners is a doctor-owned medical practice with 64 internists and 25 specialty physicians covering cardiology, dermatology, endocrinology, gastroenterology, pulmonary and sleep medicine. The practice operates 8 clinics across the Charlotte metropolitan region, totaling more than 160,000 square feet and serving more than 110,000 patients.
They announced “Tryon Direct” to self-insured mid-sized and large businesses in the Charlotte region. This new offering provides participating businesses with unlimited and same-day appointments with their primary care physicians—and will enable participating businesses to reduce their overall healthcare costs by 15-25% annually. Recognizing the administrative resource burden associated with the complexities of clinical trial conduct at the practice level, they seek to make research efficient and accessible.
Javara Inc: Integrated Research Organization (IRO)
An Integrated Research Organization driven to change the clinical research experience and expand access to clinical trial—for both providers and patients. The team includes a very seasoned group of clinical research executives. Javara brings a turnkey-practice-based clinical trials infrastructure to engage physicians and patients to participate in clinical research.
Physician Network + Integrated Research Organization equals new Clinical Research as Care Options
With the two organizations partnering in the Charlotte area they represent a potentially compelling option for biopharmaceutical sponsors and CROs seeking research sites in this part of North Carolina. As Dr. Dale Owen, CEO of Tryon Medical Partners notes, “This partnership is a win-win for our patients and doctors.” He continued, “Our patients will now have an opportunity to directly participate in advanced clinical medical trials at no cost, and our doctors will be able to work closely with Javara’s medical professionals on the development of an array of innovative new drugs and interventions.
Tryon has added a total of eight clinics and is seeing robust growth. Now Tryon patients can benefit from advanced new clinical trials and have access to the underlying infrastructure and quality support via Javara’s teams, including their Clinical Trial Navigators who are embedded in Tryon’s clinics. Trained in good clinical practices and FDA clinical quality, a heretofore not possible service—clinical research as a care option—is now possible.
The new partnership will work with clinical sponsors to sign up for new studies with a clinical trial focus on internal medicine, endocrinology and dermatology. The team expects initial clinical trials to being in September 2019. They plan on having 35 to 45 clinical trials underway within the next 18 months.